SUCHITRA NISHAL1, VIKAS JHAWAT1,*, SUMEET GUPTA2, PARMITA PHAUGAT1
Oncology Research, Vol.30, No.5, pp. 221-230, 2022, DOI:10.32604/or.2022.027549
Abstract Kinase inhibitors are a significant and continuously developing division of target therapeutics. The drug
discovery and improvement efforts have examined numerous attempts to target the signaling pathway of kinases. The
Kinase inhibitors have been heralded as a game-changer in cancer treatment. For developing kinase inhibitors as a
treatment for various non-malignant disorders like auto-immune diseases, is currently undergoing extensive research.
It may be beneficial to investigate whether cell-specific kinase inhibitor administration enhances therapeutic efficacy
and decreases adverse effects. The goal of the current review is to gain insight into the role of kinase inhibitors in
facilitating effective target drug delivery… More >
Login
Register
